课题基金 / 基金详情

Quantitative proteomic analysis of lymphoma transformation

Quantitative proteomic analysis of lymphoma transformation
淋巴瘤转化的定量蛋白质组分析
批准号:
7254275
负责人:
KOJO S. J. ELENITOBA-JOHNSON
金额:
$28.03万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2009-06-30
关键词:
3-DimensionalAccountingAdultAgreementAlgorithmsAntibodiesAnusAppendixArchivesB-Cell LymphomasBayesian AnalysisBehavior TherapyBibliographyBioinformaticsBiologicalBiological AssayBiologyBiometryBiopsyBudgetsCancer CenterCatalogingCatalogsCategoriesCell physiologyCellsCertificationClassClassificationClassification SchemeClinical DataClonalityCohort StudiesCollaborationsComputer softwareCoupledDNADataDevelopmentDiagnosisDiagnosticDiffuseDiffuse LymphomaDigestionDirect CostsDiscriminationDiseaseDropsEarly DiagnosisElementsEmerging TechnologiesEndopeptidasesEnsureEnzymesEvaluationEventExperimental DesignsFigs - dietaryFollicular LymphomaFreezingFundingGeneric DrugsGenomeGoalsGrantHealthcare SystemsHematologyHigh Performance ComputingHistologicHuman ResourcesImmunohistochemistryIndiumIndividualIndolent Clinical CourseInstitutionInvestigationLaboratoriesLeadLightLymphomaMAPK14 geneMalignant NeoplasmsMass Spectrum AnalysisMatched-Pair AnalysisMethodologyMethodsMinorMolecular GeneticsMolecular ProfilingNIH Program AnnouncementsNeoplasmsNomenclatureNon-Hodgkin&aposs LymphomaNumbersPathogenesisPathologistPathologyPathway interactionsPatientsPatternPeptide HydrolasesPeptidesPerformancePhosphoproteinsPolymerase Chain ReactionProcessProtein AnalysisProtein DeregulationProteinsProteolysisProteomeProteomicsPublished CommentPublishingRecommendationRelianceResearch DesignResearch PersonnelResourcesReverse Transcriptase Polymerase Chain ReactionReverse TranscriptionSamplingSorting - Cell MovementSourceSpecificitySpecimenSubgroupSuspension substanceSuspensionsSystemTaxonomyTechniquesTechnologyTherapeuticTimeTissuesTreatment ProtocolsTrypsinUniversitiesUtahValidationVariantWestern BlottingWorkanticancer researchbasecancer therapycohortdesignglutamyl endopeptidaseinsightinterestlarge cell Diffuse non-Hodgkin&aposs lymphomamortalityneoplasticnovelnumb proteinparallel computingpeptidyl-Lys metalloendopeptidaseprognosticprogramsprotein expressionresponsesizetandem mass spectrometrytechnology developmenttumor

项目摘要

项目成果

KOJO S. J. ELENITOBA-JOHNSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Non-Hodgkin's lymphoma accounts for approximately 50,000 new cases of cancer annually. This figure represents an increase beyond that seen for most other forms of cancer. Among the non-Hodgkin's lymphomas, follicular lymphoma represents the most common subtype of low-grade B-cell lymphoma in adults, and typically pursues an indolent clinical course. In a significant proportion of cases there is histologic transformation from a low-grade neoplasm to an aggressive diffuse large B-cell lymphoma with significantly decreased median survival. The recent advent of sophisticated mass spectrometry technology coupled with software algorithms that permit instantaneous protein identification, makes it feasible to study the pattern of protein deregulation that distinguish two biologic states. We propose to employ a combination of chromatographic techniques and tandem mass spectrometry in the identification of the alterations in protein expression that accompany histologic transformation. We shall be analyzing a cohort of matched pairs of follicular lymphoma and their transformed diffuse large B-cell lymphoma counterparts occurring in the same individual. Relevance: Comprehensive identification of the qualitative and quantitative changes in protein expression that are involved in follicular lymphoma transformation will permit the delineation of deregulated pathways, identify distinct prognostic subgroups of transformed lymphoma, and facilitate the development of novel therapies that target susceptible elements in the deregulated pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
  • 批准号:
    10655478
  • 项目类别:
  • 资助金额:
    $53.08万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
  • 批准号:
    10703746
  • 项目类别:
  • 资助金额:
    $51.11万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Genomic biomarkers of splenic lymphoma
  • 批准号:
    10703846
  • 项目类别:
  • 资助金额:
    $19.45万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
Genomic biomarkers of splenic lymphoma
  • 批准号:
    10531857
  • 项目类别:
  • 资助金额:
    $62.15万
  • 财政年份:
    2022
  • 负责人:
    KOJO S. J. ELENITOBA-JOHNSON
  • 依托单位:
海外基金